244 related articles for article (PubMed ID: 1655815)
1. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
[TBL] [Abstract][Full Text] [Related]
2. Modulation of growth factor responsiveness of murine mammary carcinoma cells by cell matrix interactions: correlation of cell proliferation and spreading.
Elliott B; Ostman A; Westermark B; Rubin K
J Cell Physiol; 1992 Aug; 152(2):292-301. PubMed ID: 1322415
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells.
Humes HD; Beals TF; Cieslinski DA; Sanchez IO; Page TP
Lab Invest; 1991 Apr; 64(4):538-45. PubMed ID: 2016859
[TBL] [Abstract][Full Text] [Related]
4. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
5. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma.
Blanckaert VD; Schelling ME; Elstad CA; Meadows GG
Cancer Res; 1993 Sep; 53(17):4075-81. PubMed ID: 8358737
[TBL] [Abstract][Full Text] [Related]
6. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
7. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
[TBL] [Abstract][Full Text] [Related]
9. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
Geistlich A; Gehring H
Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
[TBL] [Abstract][Full Text] [Related]
13. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
14. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
16. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
17. Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
Schwarz LC; Gingras MC; Goldberg G; Greenberg AH; Wright JA
Cancer Res; 1988 Dec; 48(24 Pt 1):6999-7003. PubMed ID: 3056609
[TBL] [Abstract][Full Text] [Related]
18. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Sehgal I; Baley PA; Thompson TC
Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
[TBL] [Abstract][Full Text] [Related]
20. Metastatic phenotype: growth factor dependence and integrin expression.
Perrotti D; Cimino L; Falcioni R; Tibursi G; Gentileschi MP; Sacchi A
Anticancer Res; 1990; 10(6):1587-97. PubMed ID: 2285230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
